Cervical Cancer Diagnostic Tests have become highly sophisticated with accurate diagnosis for effective treatment
There are three basic types of
cervical cancer namely squamous cell carcinoma (also known as cancer of the
cervix), adenocarcinoma, and carcinoma in the fallopian tubes. Adenocarcinomas
are the most common type and usually begin as a non-cancerous tissue. Squamous
cell carcinomas (also called vaginal cancer of the cervix) develop primarily in
the outer lining of the cervix and is normally found in 90 to 95% of cervical
cancer cases.
One of the key cervical
cancer diagnostic tests are HPV diagnostic test and they are at an
all-time high. As previously stated, research reports continue to indicate that
the future is not likely to see a slowing of the rate of new infections, but
instead an acceleration into the future. The Information presented in this
article briefly outlines two of the most important players in the cervical
cancer diagnostic tests sales, price and growth rate of HPV. A recent
development in DNA cervical cancer diagnostic tests makes it possible to
determine if a person has abnormal cells by looking at genetic material (known
as HPV DNA) found in cervical fluid. If the DNA is present, it indicates that a
person may have the disease. Unfortunately, there is no current way to
determine which type of cells a woman carries that can indicate HPV infection.
Most doctors will recommend surgery
if the tumor is large enough or if the tumor and surrounding tissue can be seen
on an ultrasound. If surgery is recommended, doctors will often combine
chemotherapy and radiation therapy. If the cancer cells have already spread to
other areas of your body, chemotherapy alone will often be enough to stop the
cancer cells from spreading. Recently, in June 2020, National Cancer Institute
(NCI) study showed that AI dual-stain approach improved efficiency, the
accuracy of cervical cancer screening.
Comments
Post a Comment